Ascendia - Making the Impossible Possible for Over a Decade

New Opportunities via Novel Formulation Technologies

Published on: 

Sponsored Video

Ascendia Pharmaceuticals CEO, Jim Huang, describes how new opportunities in formulation development complement the company’s previous work in developing novel nanotechnologies to support biopharmaceutical development.

Now Viewing
New Opportunities via Novel Formulation Technologies
Identifying the Right CDMO to Support Biopharma Manufacturing
Optimizing Drug Delivery Methods With Nanotechnologies

Jim Huang, CEO of Ascendia Pharmaceuticals discusses:

  • Ascendia Pharmaceuticals growth and culture
  • Recent advances including the company's fourth nanotechnology – LipidSol